caus
agent
infecti
diseas
tradit
identifi
use
bioassay
ii
immunodiagnosi
iii
biochem
biophys
microscop
techniqu
direct
identif
limit
merit
approach
discuss
kurstak
et
al
b
summari
bioassay
gener
sensit
often
inadequ
long
replic
time
organ
antibiot
treatment
patient
interfer
cultiv
sometim
agent
grown
vitro
rapid
diagnosi
treatment
immunodiagnosi
variou
form
continu
becom
import
identif
purpos
serolog
method
becom
refin
also
sinc
knowledg
natur
immun
respons
increas
rapidli
exampl
paradigm
igm
primari
respons
igg
secondari
respons
seem
increasingli
oversimplifi
howev
shift
rel
insensit
complex
procedur
immunodiffus
immunoelectrophoresi
agglutin
radioimmunoassay
immunofluoresc
enzym
immunoassay
direct
identif
continu
play
role
diagnosi
infecti
diseas
particularli
bacteriolog
microscopi
distinguish
introduct
relat
agent
eg
electropherogram
rotavirus
detect
virus
electron
microscopi
enzym
immunoassay
rapidli
becom
import
tool
diagnosi
infecti
diseas
increasingli
sophist
formul
assay
system
devis
gener
rule
competit
assay
use
specif
import
requir
wherea
noncompetit
assay
use
high
sensit
requir
high
specif
need
preval
diseas
low
otherwis
major
posit
test
result
fals
posit
contrast
case
diseas
high
preval
improv
sensit
greater
impact
reliabl
test
improv
specif
numer
exampl
demonstr
point
preval
diseas
ie
probabl
posit
result
obtain
specif
sensit
specif
sensit
test
total
posit
true
posit
fals
posit
would
theoret
obtain
true
posit
increas
specif
rapidli
decreas
number
fals
posit
thu
improv
greatli
reliabl
result
exampl
increas
specif
keep
sensit
almost
doubl
reliabl
convers
sensit
increas
specif
kept
fraction
true
posit
among
posit
test
result
increas
slightli
howev
high
preval
eg
complet
differ
result
emerg
specif
sensit
reliabl
posit
result
quit
good
reliabl
neg
result
rel
poor
thu
improv
reliabl
neg
result
high
preval
requir
improv
sensit
wherea
increas
specif
rel
less
impact
reliabl
result
choic
enzym
immunoassay
situat
thu
clearli
noncompetit
system
addit
step
enzymeantibodi
complex
pap
avidinbiotin
system
reason
discuss
consider
utmost
import
often
overlook
progress
enzym
immunoassay
applic
infecti
diseas
diagnosi
achiev
sever
level
improv
qualiti
standard
reagent
due
develop
hybridoma
techniqu
dna
recombin
technolog
ii
effici
conjug
procedur
minim
loss
enzym
antibodi
activ
iii
design
sophist
assay
system
kurstak
kurstak
et
al
possibl
maintain
cell
part
organ
remov
bodi
cell
tissu
cultur
frequent
use
varieti
disciplin
enzym
immunohistochemistri
prove
import
adjunct
studi
quit
similar
freshli
dissect
tissu
fixat
andor
freez
section
immun
detect
enzym
action
import
except
procedur
section
requir
cell
grown
vitro
monolay
howev
permeabil
cell
membran
necessari
intracellular
antigen
jessen
rais
two
gener
cautionari
point
use
cultur
first
cell
may
often
lose
retain
certain
degre
differenti
exampl
mirski
et
al
observ
rat
neural
bare
detect
schwann
cell
prior
cultur
wherea
cultur
unambigu
stain
peripher
glia
obtain
extrapol
vitro
studi
vivo
condit
may
therefor
unwarr
second
high
densiti
cell
vitro
eg
confluenc
avoid
sinc
lead
decreas
qualiti
reproduc
stain
cell
often
best
stain
peripheri
cell
layer
border
outgrowth
zone
infect
cell
grown
vitro
allow
studi
replic
infecti
agent
caution
warrant
extrapol
find
vivo
system
mani
interact
system
eg
immun
system
absent
vitro
nevertheless
studi
show
cell
potenti
eg
vitro
transform
import
phenomenon
among
infecti
pathogen
may
close
relat
case
herp
simplex
virus
may
subject
almost
continu
antigen
drift
influenza
virus
heterogen
variabl
hyperimmun
serum
extrem
import
characterist
immunoassay
infecti
agent
two
virus
eg
assay
monoclon
antibodi
common
determin
assay
unsuccess
distinguish
two
virus
howev
polyclon
antisera
reflect
multitud
individu
activ
direct
virus
other
result
improv
specif
polyclon
antiserum
indic
literatur
specif
bonu
extrem
howev
monoclon
antibodi
may
direct
typespecif
epitop
two
virus
result
clear
distinct
assay
monospecif
monoclon
antibodi
time
disadvantag
panel
monoclon
antibodi
desir
disadvantag
due
inabl
distinguish
agent
crossreact
determin
antigen
drift
loss
avid
affin
bonu
ehrlich
et
al
moreov
monoclon
antibodi
often
fail
precipit
antigen
disadvantag
procedur
depend
character
isol
immun
complex
problem
overcom
judici
choic
antibodi
mixtur
monoclon
antibodi
may
unusu
suscept
denatur
behav
atyp
igg
igm
molecul
precipit
often
near
p
gener
ph
given
monoclon
antibodi
certain
isotyp
may
possess
certain
biolog
activ
complement
fixat
make
imposs
use
complementbas
enzym
immunoassay
world
popul
affect
infecti
diseas
often
protozoan
helminth
higashi
popul
parasit
diseas
usual
neglect
sinc
primarili
develop
countri
constrain
due
limit
facil
train
manpow
econom
restrict
combin
environ
ideal
parasit
transmiss
tropic
subtrop
region
result
widespread
parasit
diseas
simplic
low
cost
enzym
immunoassay
therefor
real
boost
diagnosi
mani
protozoan
helminth
diseas
tend
last
benefit
new
serolog
method
fact
parasitolog
promin
posit
develop
enzym
immunoassay
isotop
assay
less
feasibl
develop
countri
world
health
organ
introduc
nonisotop
altern
great
success
usual
method
identifi
parasit
infect
examin
blood
fecal
sampl
parasit
egg
cyst
larva
microscopi
howev
method
fail
impract
extravascular
extraintestin
infect
involv
case
epidem
larg
number
sampl
process
epidemiolog
context
enzym
immunoassay
enorm
use
parasit
diseas
diagnosi
infect
often
latent
endem
region
minor
among
infect
may
show
clinic
morbid
moreov
popul
may
previous
infect
multipl
infect
enzym
immunoassay
may
consider
help
seroepidemiolog
survey
also
provid
use
adjunct
tradit
method
identifi
parasit
individu
patient
repeat
infect
certain
parasit
lead
elev
level
antibodi
igm
igg
ige
particular
helminth
class
wide
specif
extens
crossreact
import
therefor
isol
specif
antigen
order
design
assay
high
specif
schiller
simultan
progress
vitro
cultiv
hybridoma
techniqu
new
separ
techniqu
eg
hplc
led
signific
advanc
mitchel
ander
immunodiagnost
test
sensit
specif
replac
tradit
method
direct
identif
crossreact
particularli
extens
among
group
helminth
cestod
trematod
nematod
polyparasit
simultan
infect
sever
parasit
frequent
observ
mani
region
buck
et
al
complic
diagnosi
yield
incomplet
result
enzym
immunoassay
use
followup
mass
chemotherapi
campaign
environment
control
strategi
higashi
particular
problem
may
aris
fals
neg
due
presenc
circul
immun
complex
ii
fals
neg
due
frequent
abil
parasit
induc
immunosuppress
evad
immun
respons
host
antigen
mask
clinic
morbid
often
absent
case
helminth
infect
fact
morbid
depend
exposur
rate
worm
replic
human
inhabit
endem
region
adulthood
expos
least
parasit
immunoassay
must
also
abil
overcom
extens
crossreact
make
difficult
identifi
recent
infect
previou
infect
result
consider
number
fals
posit
pifer
et
al
schroeder
schistosomiasi
import
widespread
tropic
diseas
man
million
afflict
import
parasit
group
schistosoma
japonicum
schistosoma
haematobium
identifi
speciescharacterist
egg
fece
mansoni
japonicum
urin
haematobium
egg
count
intens
may
correl
clinic
morbid
none
varieti
serolog
test
complet
satisfactori
circumov
precipit
test
copt
whole
egg
incub
serum
result
posit
case
precipit
surfac
egg
shell
olivergonzalez
sensit
egg
count
fece
ruixtiben
et
al
result
neg
therapi
immunoassay
may
signific
aid
stage
infect
egg
excret
becom
scant
solubl
egg
antigen
fraction
mott
dixon
monoclon
antibodi
rais
japonicum
egg
antigendirect
monoclon
antibodi
shown
great
promis
competit
elisa
test
mitchel
etal
crude
solubl
egg
antigen
appropri
sinc
demonstr
crossreact
fascioliasi
hydatidosi
cysticercosi
trichinosi
hillyer
gomez
de
rio
major
antigen
copt
reaction
hillyer
pelley
less
specif
sensit
radioimmunoassay
fraction
egg
antigen
enhanc
sensit
specif
elisa
mclaren
etal
differenti
chronic
acut
infect
attempt
success
proteoglycan
adult
worm
nash
et
al
patient
activ
infect
antibodi
antigen
kelso
weiler
howev
circul
schistosom
antigen
probabl
immun
complex
echinococcu
granulosi
echinococcu
multiloculari
canin
tapeworm
egg
ingest
human
develop
larva
migrat
viscera
heart
liver
lung
brain
grow
cystic
form
morbid
depend
number
site
cyst
initi
elisa
suffer
lack
specif
ambrois
thoma
desgeorg
howev
capron
et
al
isol
antigen
call
arc
antibodi
almost
alway
present
sera
patient
sampl
enzymelink
electroimmunodiffus
assay
use
antigen
show
sensit
sera
specif
sera
pinon
et
al
antigen
speci
specif
also
present
tapeworm
vareladiaz
et
al
patient
perhap
cysticercosi
may
also
antibodi
antigen
schantz
et
al
howev
decreas
diagnost
valu
detect
antigen
sinc
geograph
distribut
parasit
chiefli
separ
clinic
differenti
possibl
schistosom
antigen
circul
immun
complex
may
caus
fals
neg
richardlenobl
et
al
strain
variat
differ
region
thompson
kumaratilak
site
number
cyst
least
detect
lung
brain
also
contribut
fals
neg
reaction
ingest
embryon
egg
taenia
solium
hatch
intestin
larva
enter
circul
develop
cyst
may
caus
sever
morbid
depend
site
fals
neg
quit
high
neurocysticercosi
flisser
et
al
probabl
due
poor
humor
immunorespons
howev
recent
advanc
enzym
immunoassay
improv
detect
diwan
et
al
espinoza
et
al
particularli
antibodi
assay
cerebrospin
fluid
improv
assay
still
requir
detect
import
antigen
onchocerca
volvulu
caus
ocular
complic
skin
diseas
depend
worm
burden
diseas
occur
primarili
latin
american
africa
latter
contin
sever
filari
parasit
may
infect
human
crossreact
problem
howev
latin
america
particularli
guatemala
mexico
usual
free
filari
parasit
make
immunoassay
specif
use
higashi
crossreact
observ
sera
patient
loiasi
hydatid
diseas
ambroisethoma
et
al
de
mouti
et
al
produc
monoclon
antibodi
readili
react
circul
antigen
number
fals
neg
nevertheless
quit
high
amount
circul
antigen
relat
microfilari
densiti
one
infect
domest
anim
prevent
reach
man
helminth
trichinella
spirali
frequent
infect
pig
preval
man
much
higher
unit
state
annual
report
case
unit
state
ruitenberg
cowork
recogn
earli
valu
enzym
immunoassay
mass
screen
ruitenberg
van
knapen
though
much
earli
work
done
sera
human
engval
ljungstrom
gambl
graham
isol
two
protein
mw
respect
mean
affin
chromatographi
use
monoclon
antibodi
antigen
react
sera
infect
swine
elisa
littl
larva
per
g
muscl
could
detect
toxocara
cani
may
caus
sever
diseas
young
children
develop
countri
viscer
larva
migran
ocular
toxocariasi
larval
extract
use
design
elisa
test
reason
high
sensit
specif
glickman
et
al
de
savigni
eleg
method
develop
de
savigni
et
al
use
secretori
antigen
van
knapen
et
al
compar
use
secretori
larval
antigen
somat
adult
antigen
billion
peopl
live
endem
region
brucechwatt
almost
half
live
area
transmiss
uncheck
resist
mosquito
vector
insecticid
develop
drug
resist
plasmodium
falciparum
pose
major
obstacl
control
measur
wyler
test
parasit
high
speci
specif
sinc
p
falciparum
caus
almost
acut
mortal
case
purpos
major
polypeptid
isol
da
silva
et
al
monoclon
antibodi
polypeptid
effect
neutral
parasit
vitro
growth
kemp
et
al
clone
gene
p
falciparum
code
immunogen
protein
escherichia
coli
could
provid
larg
amount
antigen
assay
howev
schofield
et
al
demonstr
monoclon
antibodi
differ
reactiv
exist
among
isol
parasit
differ
region
elisa
develop
detect
p
falciparum
make
possibl
detect
parasit
per
erythrocyt
mackey
et
al
fraction
fals
neg
increas
howev
blood
contain
high
antimalari
antibodi
titer
thu
lower
predict
valu
trypanosoma
brucei
gambiens
caus
chronic
infect
wherea
trypanosoma
brucei
rhodiensiens
caus
acut
diseas
infect
african
trypanosom
sleep
diseas
result
high
igm
level
low
antibodi
concentr
probabl
sinc
seem
strong
polyclon
b
cell
activ
problem
african
trypanosom
antigen
drift
result
cyclic
antigen
variat
elisa
test
reason
sensit
specif
ruitenberg
buy
picq
et
al
particularli
common
variant
antigen
use
vervoort
et
al
chaga
diseas
american
trypanomiasi
caus
trypanosoma
cruzi
widespread
latin
america
million
brener
voller
et
al
develop
elisa
excel
sensit
high
fraction
fals
posit
spencer
et
al
particularli
sera
patient
leishmaniasi
guimara
et
al
specif
test
therefor
improv
interest
approach
taken
crane
dvorak
fuse
cruzi
murin
myeloma
cell
obtain
hybrid
produc
protozoan
antigen
immunoassay
entamoeba
histolytica
import
case
extraintestin
diseas
sinc
parasit
usual
detect
stool
elisa
employ
use
bo
et
al
particularli
captur
assay
pillai
mohimen
kineticdepend
elisa
matthew
et
al
latter
requir
rapid
process
computercontrol
micropl
reader
drawback
develop
countri
giardiasi
often
identifi
intestin
parasit
unit
state
elisa
develop
detect
igg
antibodi
giardia
lamblia
smith
et
al
abl
detect
prove
case
fals
posit
pneumocysti
carinii
import
caus
agent
pneumon
chiefli
immunocompromis
children
person
malign
aid
hugh
gottlieb
etal
elisa
ubiquit
parasit
yet
well
develop
maddison
et
al
leggiadro
et
al
though
urgent
need
exist
toxoplasma
gondii
univers
distribut
often
caus
clinic
inappar
infect
earli
test
detect
parasit
establish
serum
titer
use
enzymelabel
antibodi
perform
immunoperoxidas
techniqu
kurstak
et
al
similar
wide
use
indirect
immunofluoresc
antibodi
test
fig
subsequ
studi
use
antigen
immobil
microtit
plate
voller
et
al
class
captur
assay
success
detect
igm
antibodi
gondii
naot
remington
therebi
avoid
nonspecif
reaction
due
antinuclear
antibodi
rheumatoid
factor
payn
et
al
recent
organon
teknika
belgium
market
toxonostika
microelisa
test
detect
igm
igg
serum
plasma
gondii
tabl
offer
good
perform
sensit
specif
antigenemia
acut
infect
detect
circul
antigen
feasibl
araujo
remington
interestingli
polyclon
antisera
rabbit
better
suit
purpos
murin
monoclon
antibodi
araujo
et
al
recent
work
pinon
et
al
describ
enzymelink
immunofiltr
assay
use
compar
infant
matern
antibodi
profil
toxoplasmosi
assay
carri
micropor
membran
doubli
analyt
method
permit
simultan
studi
antibodi
specif
immunoprecipit
character
antibodi
isotyp
immun
filtrat
enzymelabel
antibodi
method
use
detect
igm
antibodi
distinguish
transmit
matern
igg
igg
antibodi
synthetis
fetu
neonat
make
diagnosi
congenit
toxoplasmosi
possibl
case
first
day
life
method
diagnosi
may
made
averag
month
earlier
classic
methodolog
use
monoclon
antibodi
doublesandwich
elisa
also
propos
detect
igm
antibodi
major
surfac
protein
gondii
especi
diagnosi
acut
acquir
toxoplasmosi
cesbron
et
al
method
base
captur
serum
igm
antibodi
reveal
indirectli
addit
gondii
extract
monoclon
antibodi
antihuman
monoclon
antibodi
also
use
detect
igm
antibodi
gondii
revers
immunosorb
assay
pouletti
et
al
reagent
prepar
wash
buffer
dilut
volum
concentr
buffer
volum
distil
water
ml
per
strip
sera
must
dilut
dilut
buffer
see
least
serum
ml
buffer
control
dilut
buffer
brought
well
pipet
well
directli
control
buffer
prepar
igm
conjugateantigen
mixtur
ad
ml
dilut
buffer
ampoul
igm
conjug
antigen
one
everi
strip
mix
two
ratio
prepar
igg
conjug
ad
ml
dilut
buffer
ampoul
igg
conjug
one
everi
strip
mix
well
prepar
peroxidesubstr
buffer
ad
ml
urea
peroxid
solut
one
tablet
ml
distil
water
vial
substrat
buffer
prepar
substrat
ad
ml
reconstitut
peroxidesubstr
buffer
see
ml
distil
water
ad
tmb
solut
mix
solut
colorless
use
suffici
four
strip
assay
procedur
pipet
correspond
dilut
control
see
reagent
well
al
dilut
serum
plasma
remain
well
appropri
microelisa
strip
code
tl
igg
igm
seal
adhes
tape
incub
incub
cover
water
bath
high
rel
humid
min
incub
prepar
igm
conjugateantigen
reagent
igg
conjug
reagent
wash
strip
four
time
buffer
reagent
add
well
igm
strip
conjugateantigen
mixtur
reagent
igg
strip
conjug
reagent
seal
adhes
tape
incub
min
prepar
reagent
wash
strip
four
time
buffer
reagent
add
substrat
reagent
well
incub
dust
free
min
stop
color
reaction
ad
n
sulfur
acid
read
result
photometr
nm
mean
neg
posit
control
toxonostika
igm
igg
microelisa
system
organon
teknika
belgium
enzym
immunoassay
bacteriolog
employ
detect
bacteri
antigen
antibodi
determin
extracellular
antigen
toxin
antibodi
level
antiantibiot
antibodi
antibioticsensit
patient
haan
et
al
haan
et
al
reason
discuss
chapter
section
direct
detect
causal
agent
diseas
often
requir
ie
rapid
treatment
diseas
imposs
develop
antibodi
await
tradit
bacteria
identifi
cultur
microscopi
procedur
often
rapid
precis
respect
enzym
immunoassay
therefor
latter
use
wide
infecti
diseas
virolog
parasitolog
altern
diagnost
method
use
nevertheless
enzym
immunoassay
increasingli
appli
bacteriolog
particularli
case
altern
less
satisfactori
antibodi
diagnosi
often
essenti
retrospect
studi
though
immun
respons
bacteria
complex
sinc
cellmedi
immun
much
import
smaller
antigen
protein
virus
lipopolysaccharid
lp
import
mani
gramneg
bacteria
enzym
immunoassay
prime
candid
detect
differenti
glynn
ison
either
antibodi
antigen
attach
solid
phase
polysaccharid
attach
protein
bridg
cyanogen
halid
axen
et
al
benzoquinon
girard
goichot
stiller
nielsen
describ
method
lp
conjug
consider
effici
other
affin
purif
bovin
antibodi
bruceila
abortu
lp
base
acetonitrilecnbr
method
method
allow
largescal
isol
affinitypurifi
antibodi
lp
consider
potenti
standard
serolog
procedur
screen
confirm
test
butler
et
al
butler
kusama
develop
doubleantibodi
sandwich
method
detect
lp
eight
preval
pseudomena
aeruginosa
serotyp
import
p
aeruginosa
opportunist
pathogen
nosocomi
infect
increasingli
recogn
lp
specif
highli
immunogen
respons
variou
clinic
manifest
releas
surround
medium
kusama
observ
lp
ii
higher
reactiv
enzym
immunoassay
lp
fraction
ii
separ
gel
filtrat
could
due
differ
avid
sinc
morrison
leiv
observ
similar
differ
immunodiffus
studi
e
coli
lp
fraction
howev
goldman
et
al
show
e
coli
lp
neither
lipid
oligosaccharid
core
munford
hall
improv
detect
gramneg
bacteri
lp
increas
solubl
lp
triethylamin
kusama
fail
confirm
enzym
immunoassay
howev
kusama
demonstr
enzym
immunoassay
use
lp
ii
highli
sensit
specif
variou
serotyp
p
aeruginosa
carlsson
et
al
screen
matern
serum
cord
blood
human
milk
antibodi
e
coli
lp
similarli
gripenberg
et
al
demonstr
antibodi
yersinia
enterocolitica
lp
human
serum
enzym
immunoassay
result
quit
often
differ
consider
obtain
hemagglutin
antigen
could
also
detect
present
member
genu
brucella
infect
differ
speci
anim
member
genu
may
also
transmit
human
eg
b
sui
normal
infect
swine
b
abortu
normal
infect
bovin
b
melitensi
b
cani
normal
infect
sheep
dog
respect
b
ovi
sheep
known
infect
human
though
brucella
cultiv
brucellosi
variabl
incub
time
abrupt
insidi
onset
major
test
confirmatori
base
serolog
particularli
agglutin
mccullough
enzym
immunoassay
use
especi
veterinari
medicin
carrier
detect
examin
milk
serum
antibodi
byrd
et
al
thoen
et
al
serv
erad
program
howev
ideal
microbi
antigen
detect
directli
perera
et
al
devis
enzym
immunoassay
high
detect
lp
produc
brucella
abl
detect
fgml
solubil
crude
lp
brucella
cell
concentr
sampl
serum
plasma
lp
could
detect
though
brucella
ad
suspens
leukocyt
ml
normal
bovin
blood
readili
measur
failur
detect
lp
concentr
undilut
serum
may
due
inhibitori
factor
though
b
abortu
shed
milk
detect
imper
pregnant
last
trimest
nonlactari
anim
mani
diseas
requir
rapid
diagnosi
proper
treatment
cultur
often
slow
made
imposs
earli
administr
antibodi
glynn
ison
exampl
bacteri
caus
acut
mening
often
diagnos
counterimmunoelectrophoresi
greenwood
et
al
howev
techniqu
fail
detect
antigen
substanti
number
patient
scheifel
et
al
thirumoorthi
dajani
collin
kelli
howev
enzym
immunoassay
least
higher
detect
drew
et
al
e
coli
k
antigen
close
relat
crossreac
hand
kaplan
et
al
employ
enzym
immunoassay
detect
capsular
antibodi
h
influenza
type
b
purpos
polyribosephosph
prp
capsul
h
influenza
coupl
polyllysin
sinc
alon
adsorb
reliabl
microtit
plate
prior
adsorpt
antiprp
antibodi
plastic
often
result
excess
nonspecif
adsorpt
test
sera
comparison
radioimmunoassay
kaplan
et
al
koskela
leinonen
inconclus
respect
detect
sensit
far
surpris
sinc
underli
principl
method
differ
often
radioimmunoassay
h
influenza
antibodi
base
satur
analysi
wherea
enzymemedi
method
base
immunometr
assay
inher
sensit
specif
level
differ
independ
label
use
common
caus
neonat
sepsi
mening
group
b
streptococcu
mortal
infant
earlyonset
infect
prevent
vertic
transmiss
rapid
identif
mother
whose
infant
may
develop
infect
necessari
morrow
et
al
develop
monoclon
sandwich
enzym
immunoassay
abl
detect
ngml
nativ
antigen
serotyp
specif
wherea
polin
kennett
devis
competit
immunoassay
also
base
monoclon
antibodi
purpos
meningococc
mening
usual
diagnos
cultur
howev
detect
antigen
enzym
immunoassay
compar
advantag
serolog
procedur
sippel
voller
sugasawara
et
al
particular
latter
studi
monoclon
antibodi
use
sugasawara
et
al
heatlabil
enterotoxin
vibrio
cholera
e
coli
pathogen
strain
detect
convent
enzym
immunoassay
great
advantag
holmgren
svennerholm
svennerholm
holmgren
svennerholm
wiklund
yolken
etal
beutin
etal
modifi
method
use
nitrocellulos
membran
solid
phase
detect
ngml
normal
adult
clostridium
perfringen
fecal
flora
identif
organ
would
insuffici
diagnosi
bryan
clostridium
eneterotoxin
howev
success
detect
enzym
immunoassay
lewi
et
al
lyerli
et
al
mcclane
strous
jackson
et
al
mcclane
strous
note
presenc
fecal
materi
appar
decreas
sensit
sandwich
assay
interest
note
materi
gener
high
proteolyt
activ
may
caus
desorpt
captur
antibodi
immobil
plate
viscidi
et
al
bacteria
nonspecif
affin
igg
eg
staphylococcu
aureu
may
contain
high
level
protein
may
interfer
enzym
immunoassay
prevent
undesir
reaction
normal
serum
may
ad
prior
test
et
al
aureu
import
among
hospitalacquir
infect
enzym
immunoassay
offer
advantag
gel
diffus
counterimmunoelectrophoresi
techniqu
gener
use
detect
aureu
infect
carruth
et
al
comparison
four
version
enzym
immunoassay
show
sandwich
design
label
antibodi
satisfactori
fey
et
al
detect
staphylococc
enterotoxin
ngml
far
clinic
relev
test
kit
commerci
avail
mani
procedur
detect
toxin
base
sandwich
method
method
requir
second
antibodi
layer
ie
solidphas
antibodi
test
sampl
toxin
either
conjug
enzym
differ
speci
antiimmunoglobulin
would
react
nonspecif
solidphas
antibodi
may
pose
problem
mani
case
sinc
antibodi
eg
staphylocc
enterotoxin
present
avail
deriv
rabbit
prohibit
use
antirabbit
igg
mani
laboratori
posit
customconjug
enterotoxin
antibodi
de
jong
devis
simpl
eleg
method
circumv
problem
test
de
jong
immobil
antibodi
dilut
carbon
buffer
appli
test
sampl
may
contain
enterotoxin
de
jong
mix
dilut
enterotoxin
antibodi
dilut
antirabbit
igg
alkalin
phosphatas
conjug
incub
hr
normal
serum
dilut
ad
incub
min
ad
plate
detect
test
least
ng
enterotoxin
per
ml
lowest
level
consid
necessari
enterotoxin
test
reiser
ere
complic
endotoxin
detect
enzym
immunoassay
frequent
contamin
commerci
peroxidas
alkalin
phosphatas
conjug
endotoxin
klipstein
et
al
exampl
commerci
obtain
bovin
alkalin
phosphatas
may
contain
much
endotoxin
per
ml
ubiqu
endotoxin
conjug
preval
antibodi
endotoxin
mammalian
sera
may
significantli
alter
valu
obtain
reliabl
assay
enzym
immunoassay
offer
noncultur
altern
detect
neisseria
gonorrhoea
antigen
urogenit
swab
commerci
kit
gonozym
market
abbott
laboratori
tabl
gonozym
solidphas
enzym
immunoassay
detect
gonococc
antigen
presenc
absenc
n
gonorrhea
determin
relat
absorb
unknown
specimen
cutoff
valu
cutoff
valu
absorb
neg
control
mean
ncx
plu
factor
unknown
sampl
absorb
valu
greater
equal
cutoff
valu
establish
neg
control
consid
posit
n
gonorrhoea
gonozym
test
accord
abbott
laboratori
b
solut
antimicrobi
agent
urethr
endocerv
swab
test
may
detect
n
gonorrhoea
fail
grow
select
media
sensit
bacteria
antibiot
viabl
gonozym
test
treat
bead
incub
swab
specimen
appropri
control
bacteria
posit
swab
specimen
adsorb
bead
bead
incub
antibodi
n
gonorrhoea
react
gonococci
bead
next
bead
incub
antibodyenzym
conjug
contain
horseradish
peroxidas
react
antigenantibodi
complex
bead
enzym
reaction
incub
wash
bead
ophenylenediamin
opd
contain
hydrogen
peroxid
h
determin
use
spectrophotomet
wavelength
set
nm
current
method
use
identifi
n
gonorrhoea
endocerv
cultur
appear
detect
less
papasian
et
al
evalu
commerci
enzym
immunoassay
kit
found
sensit
specif
specimen
male
femal
would
appear
kit
less
suitabl
detect
n
gonorrhoea
femal
studi
confirm
report
aardoom
et
al
schachter
et
al
contradict
similar
evalu
danielsson
et
al
investig
agre
assay
high
sensit
specif
detect
specimen
male
wide
discrep
result
specimen
femal
may
due
differ
specimen
collect
may
papasian
et
al
point
due
lack
immunolog
specif
posit
predict
valu
use
commerci
kit
lower
femal
need
improv
possibl
howev
choic
cultur
standard
may
optim
sinc
standard
may
fals
neg
commerci
kit
result
may
fact
correct
though
studi
stamm
et
al
suggest
howev
assay
could
major
impact
control
spread
gonorrhea
improv
cervic
gonorrhea
symptomat
gonorrhea
gram
stain
inexpens
adequ
studi
gonozym
kit
smeltzer
et
al
found
elisa
procedur
base
detect
outer
membran
complex
n
gonorrhoea
altern
method
gonorrhoea
diagnosi
men
women
geisel
et
al
point
gonozym
compar
gram
stain
rapid
diagnosi
gonorrhea
femal
enzym
immunoassay
western
blot
relat
techniqu
use
character
detect
immunodomin
surfaceexpos
protein
antigen
treponema
pallidum
moskophidi
use
monoclon
antibodi
antigen
possibl
diagnos
human
syphili
infect
character
pallidum
protein
antigen
common
sexual
transmit
diseas
infect
chlamydia
trachomati
holm
morisset
kurstak
mani
sexual
transmit
infect
respiratori
tract
infect
asymptomat
benign
syndrom
attribut
agent
cerviti
urethr
salping
proctiti
conjunct
pneumonia
infertil
women
jone
et
al
jone
et
al
common
method
diagnosi
isol
organ
tissu
cultur
method
expens
recoveri
rate
affect
mani
variabl
reev
et
al
identif
chlamydi
antibodi
specif
tissu
cultur
use
adjunct
particularli
epidemiolog
studi
though
schachter
et
al
suggest
detect
igm
method
choic
diagnosi
chlamydi
pneumonia
infant
finn
et
al
found
poor
correl
igm
detect
elisa
current
method
mahoni
et
al
observ
limit
sensit
chlamydi
igm
elisa
contrast
finn
et
al
found
satisfactori
correl
techniqu
igg
detect
elisa
serotyp
elementari
bodi
use
antigen
studi
jone
et
al
compar
reticul
elementari
bodi
antigen
elisa
detect
antibodi
chlamydia
trachomati
elementari
bodi
antigen
singl
immunotyp
may
detect
antibodi
anoth
immunotyp
wherea
reticul
bodi
antigen
appear
group
reactiv
nevertheless
jone
et
al
jone
et
al
found
broad
reactiv
antigen
less
reticul
elementari
bodi
antigen
requir
obtain
equival
bind
antibodi
mahoni
et
al
observ
howev
elisa
test
fals
neg
obtain
c
j
serotyp
possess
littl
antigen
related
serotyp
major
serolog
problem
diagnosi
genit
chlamydi
infect
remain
rel
high
background
wang
et
al
schachter
et
al
background
may
due
autoantibodi
sarkku
et
al
known
occur
chlamydi
infect
andersen
immunoperoxidas
method
use
laboratori
detect
c
tramomati
antigen
babi
hamster
kidney
cell
patient
specimen
satisfactori
fig
superior
histochem
stain
raymond
et
al
demonstr
good
agreement
result
obtain
elisa
microimmunofluoresc
assay
detect
antibodi
c
trachomati
enzym
immunoassay
detect
chlamydia
trachomati
urogenit
swab
specimen
chlamydiazym
diagnost
kit
abbott
laboratori
base
principl
gonozym
wide
use
chlamydiazym
util
solidphas
eia
detect
chlamydi
antigen
urethr
endocerv
swab
provid
result
less
hr
serodiagnosi
rickettsia
prove
possibl
sensit
enzym
immunoassay
develop
dasch
et
al
crum
et
al
dasch
et
al
adopt
elisa
serolog
diagnosi
infect
scrub
typhu
rickettsia
rickettsia
tsutsugamushi
strain
show
import
antigen
divers
antigen
easili
prepar
dasch
et
al
show
singl
antigen
could
use
differ
strain
though
differ
titer
observ
elisa
prefer
immunofluoresc
method
crum
et
al
develop
paper
elisa
purpos
dasch
develop
simpl
procedur
select
isol
protect
speciesspecif
protein
antigen
rickettsia
typhi
rickettsia
prowazekii
satisfactori
elisa
serodiagnosi
scrub
typhu
tsutsugamushi
fever
also
prove
possibl
indirect
immunoperoxidas
method
fig
yamamoto
minamishima
homogen
spleen
mice
infect
rickettsia
inject
intraperiton
mice
follow
cyclophosphamid
inject
periton
smear
obtain
use
detect
antibodi
sera
patient
weilfelix
reaction
test
overr
fact
half
fatal
case
japan
neg
test
ideal
enzym
immunoassay
would
enabl
direct
detect
viral
antigen
thu
offer
possibl
rapid
diseas
manag
unfortun
often
possibl
low
concentr
differ
serotyp
viremia
certain
stage
diseas
serolog
test
help
differ
situat
case
viru
detect
equivoc
interpret
ii
case
viru
suspect
direct
detect
difficult
time
consum
eg
myocarditispericard
due
coxsackievirus
type
possibl
influenza
b
rubella
due
rubellaviru
central
nervou
system
syndrom
due
hsv
mump
western
eastern
equin
enceph
st
loui
enceph
california
enceph
perhap
lymphocyt
choriomening
epsteinbarr
viru
iii
heterophileneg
mononucleosi
syndrom
cytomegaloviru
epsteinbarr
viru
iv
situat
immun
statu
establish
singl
sera
rubella
hepat
b
varicellazost
wi
k
fig
indirect
immunoperoxidas
stain
rickettsia
tsutsugamushi
cytosmear
periton
cell
sera
patient
use
primari
antibodi
peroxidaseconjug
goat
igg
direct
either
f
ab
shown
fc
shown
b
fraction
human
igg
courtesi
dr
yoichi
minamishima
dr
seigo
yamamoto
permiss
reproduc
gener
virus
excel
immunogen
antigen
mani
virus
antigen
epitop
specif
group
groupspecif
gs
antigen
eg
rotavirus
though
latter
socal
pararotavirus
discov
lack
gs
antigen
rapid
replic
virus
evolutionari
stress
due
erad
protect
program
may
result
antigen
drift
virus
particularli
evid
type
influenza
virus
laver
antigen
shift
massiv
major
antigen
shift
suddenli
major
antigen
shift
virus
may
occur
appear
virus
differ
hemagglutinin
sometim
neuramidas
due
complet
replac
rna
segment
code
antigen
twelv
distinct
hemagglutinin
subtyp
recogn
hemagglutin
subtyp
exist
virus
bird
lower
mammal
also
slow
steadi
antigen
drift
larg
number
antigen
variant
isol
character
monoclon
antibodi
gerhard
webster
threedimension
structur
hemagglutinin
recent
character
wilson
et
al
contain
four
independ
antigen
area
one
buri
distant
end
molecul
analysi
sequenc
chang
field
strain
reveal
drift
occur
posit
may
neighbor
posit
laver
singl
sequenc
chang
may
suffici
total
abolish
affin
monoclon
antibodi
hemagglutinin
similar
situat
seem
exist
neuramidas
webster
et
al
schild
unfortun
rel
littl
known
natur
cellmedi
immun
respons
recognit
thelper
cell
epitop
hemagglutin
differ
subtyp
investig
chemic
natur
viralantigen
drift
crucial
develop
reliabl
immunoassay
sinc
detect
antigen
critic
diagnosi
detect
antibodi
primari
immun
respons
antibodi
produc
usual
igm
class
though
recogn
igg
antibodi
appear
almost
simultan
cradockwatson
et
al
transient
natur
igm
antibodi
primari
respons
provid
tool
recogn
primari
viral
infect
schluederberg
use
basi
routin
laboratori
diagnosi
order
distinguish
igm
igg
antibodi
sever
physic
method
use
base
molecular
weight
charg
differ
gel
filtrat
sucros
gradient
centrifug
select
precipit
igg
ionexchang
chromatographi
anoth
method
use
base
observ
avid
igm
decreas
drastic
subunit
igm
molecul
dissoci
treatment
mercaptan
banatvala
et
al
howev
obtain
fourfold
decreas
titer
least
total
antibodi
must
igm
class
meurman
method
therefor
sensit
forghani
et
al
origin
enzym
immunoassay
antigen
coat
plastic
follow
incub
serum
incub
label
antiigm
antibodi
parallel
incub
label
antiigg
antibodi
setup
suffer
sever
problem
igg
compet
igm
serum
antigen
avid
differ
may
bia
result
ii
rheumatoid
factor
may
adsorb
nonspecif
complex
igg
therebi
result
fals
posit
class
captur
assay
design
ria
adopt
duermey
van
der
veen
enzym
immunoassay
use
mainli
hepat
virus
rubella
viru
flavi
virus
herp
virus
design
assay
discuss
chapter
section
l
improv
igm
test
significantli
sinc
competit
igg
igm
elimin
method
shorten
label
antigen
schmitz
et
al
van
loon
et
al
method
may
drawback
howev
igm
extract
serum
irrespect
whether
antibodi
sensit
test
relat
directli
ratio
specif
igm
antibodi
total
antibodi
heinz
et
al
nonspecif
bind
directli
relat
dilut
factor
law
mass
action
seem
higher
igm
igg
meurman
bind
involv
two
type
reaction
nonspecif
adsorpt
immunoglobulin
antigen
prepar
ii
immunolog
reaction
nonspecif
antibodi
antinuclear
anticellular
contamin
antigen
prepar
use
crude
antigen
therefor
alway
possibl
forghani
schmidt
though
virus
measl
mump
herpesvirus
excel
result
obtain
crude
extract
nonspecif
adsorpt
hand
decreas
preincub
inert
protein
bsa
gelatin
import
caus
fals
posit
result
presenc
rheumatoid
factor
antiigg
antibodi
igm
class
rheumatoid
factor
react
sever
igg
explain
accord
law
mass
action
rheumatoid
factor
steeper
doserespons
curv
meurman
ziola
dilut
therefor
one
measur
taken
decreas
interfer
figur
show
rheumatoid
factor
may
interfer
classcaptur
assay
rheumatoid
factor
product
often
activ
pregnanc
make
diagnosi
congenit
infect
difficult
reimer
et
al
also
depend
viru
meurman
detect
fals
posit
igm
antibodi
routin
rubella
serolog
one
everi
sera
wherea
hoffmann
et
al
found
time
less
fals
posit
test
tickborn
enceph
igm
igg
antibodi
tickborn
enceph
rare
note
rheumatoid
factor
may
play
import
role
pathogenesi
rheumatoid
arthriti
tarkowski
et
al
recent
develop
enzymelink
immunospot
assay
enumer
cell
secret
igg
rheumatoid
factor
simultan
quantit
igg
rf
secret
rheumatoid
factor
interfer
elimin
degre
sever
way
igg
remov
practic
eg
protein
procedur
found
effect
johnson
libbi
hand
rheumatoid
factor
may
elimin
greater
lesser
extent
polymer
igg
heat
aggreg
meurman
ziola
leinikki
et
al
glutaraldehyd
krishna
et
al
igglatex
particl
vejtorp
none
method
complet
satisfactori
shown
fail
certain
case
import
rememb
enzym
immunoassay
antibodi
label
enzym
tend
aggreg
lead
fals
posit
sera
rheumatoid
factor
yolken
leister
yolken
et
al
f
ab
react
rheumatoid
factor
sinc
lack
fc
prime
candid
classcaptur
assay
heterolog
igm
antibodi
reaction
may
occur
quit
often
close
relat
virus
aaskov
davi
burk
nisalak
though
titer
tend
low
requir
highli
purifi
antigen
katz
crowel
may
also
provid
mean
perform
groupspecif
diagnosi
major
problem
igm
diagnosi
lack
igm
respons
young
children
local
infect
eg
respiratori
syncyti
viru
welliv
et
al
influenza
b
viru
goldwat
et
al
echovirus
reiner
wecker
rotavirus
mclean
et
al
hand
igm
respons
may
occur
secondari
respons
harcourt
et
al
van
loon
etal
case
moreov
larg
variat
igm
respons
exist
igm
antibodi
may
sometim
transient
case
persist
year
stallman
et
al
often
relat
complex
infect
pregnanc
immunosuppress
chronic
infect
dormey
et
al
rotavirus
infect
gastrointestin
tract
individu
mani
speci
includ
man
clinic
serolog
consequ
age
depend
infect
may
asymptomat
newborn
babi
without
gener
persist
antibodi
gust
et
al
wherea
young
children
infect
result
mostli
acut
diarrhea
appear
persist
antibodi
flewett
babiuk
reinfect
later
age
symptomat
asymptomat
rais
antibodi
titer
diseas
occur
endem
epidem
form
estim
second
frequenc
common
cold
unit
state
cukor
blacklow
sever
virus
may
caus
gastroenter
identif
character
caus
agent
need
understand
epidemiolog
immunolog
manag
diseas
among
virus
caus
gastroenter
rotaviru
norwalk
viru
medic
import
etiolog
agent
enter
adenovirus
calicivirus
astrovirus
coronavirus
also
implic
though
host
viru
like
particl
found
diarrheal
stool
specimen
electron
microscopi
classif
rotavirus
confus
human
rotaviru
could
cultiv
base
differ
immunolog
techniqu
zissi
lambert
distinguish
two
human
serotyp
relationship
two
type
elucid
rescu
techniqu
noncultiv
rotaviru
gene
assort
mix
infect
bovin
rotaviru
greenberg
et
al
kalica
et
al
demonstr
subgroup
specif
determin
major
inner
capsid
protein
serotyp
specif
outer
capsid
glycoprotein
serotyp
four
human
rotavirus
distinguish
neutral
antibodi
wherea
subgroup
distinguish
eg
elisa
electropherotyp
unlik
use
classif
chanock
et
al
sinc
mani
differ
electropherotyp
distinguish
differ
one
detect
case
spencer
et
al
differ
sequenc
necessarili
correl
differ
migrat
pattern
cukor
blacklow
suggest
electropherotyp
may
use
limit
epidem
studi
antigen
drift
evolut
new
rotaviru
strain
rotaviru
antigen
local
cell
direct
immunoperoxidas
techniqu
kurstak
et
al
high
resolut
fig
recent
grom
bernard
describ
enzymelink
cell
immunoassay
detect
rotaviru
antigen
advantag
cell
cultur
system
viru
isol
combin
enzym
immunodetect
spectrophotometr
read
test
cultiv
human
rotaviru
adequ
diagnost
purpos
sinc
isol
rate
low
sever
passag
may
need
contrast
electron
microscopi
may
use
though
limit
institut
highli
special
equip
personnel
moreov
number
specimen
check
rather
limit
solidphas
immunoassay
use
rotaviru
detect
yolken
origin
enzym
immunoassay
reactiv
test
specimen
compar
reactiv
known
neg
stool
sampl
yolken
et
al
neutral
test
hightit
antirotaviru
serum
thought
unnecessari
routin
test
howev
becam
clear
frequenc
nonspecif
reaction
high
kraus
et
al
differ
modif
made
improv
reliabl
ad
normal
serum
reduc
chelat
agent
proteas
inhibit
ph
neutral
hammond
et
al
hogg
davidson
hovi
et
al
beard
et
al
kraus
et
al
found
commerci
rotazym
eia
unreli
neonat
specimen
rotazym
test
seem
less
sensit
indirect
enzym
immunoassay
cukor
blacklow
rotazym
test
abbott
laboratori
tabl
base
use
antisimian
rotaviru
serum
assay
depend
fact
simian
sah
human
rotavirus
share
common
group
antigen
cukor
et
al
prepar
monoclon
antibodi
common
rotaviru
antigen
sixth
viral
gene
product
reagent
superior
sensit
specif
rotazym
studi
howev
includ
diarrheal
stool
neonat
coulson
holm
develop
improv
enzymelink
immunosorb
assay
detect
rotavirus
fece
neonat
first
incub
pipet
control
dilut
specimen
appropri
reaction
tube
tray
well
add
one
bead
tube
well
contain
specimen
control
appli
cover
seal
gentli
tap
tube
tray
cover
bead
sampl
remov
trap
air
bubbl
incub
min
discard
cover
seal
wash
bead
three
time
ml
distil
deioniz
water
second
incub
add
enzym
conjug
tube
well
appli
new
cover
seal
tap
tube
tray
gentli
incub
min
prepar
opd
substrat
solut
min
prior
color
develop
discard
cover
seal
wash
bead
three
time
ml
distil
deioniz
water
remov
excess
liquid
tube
tray
aspir
blot
color
develop
immedi
transfer
bead
eia
assay
tube
add
opd
substrat
solut
assay
tube
two
empti
tube
substrat
blank
cover
incub
room
temperatur
min
immedi
compar
color
intens
tube
color
chart
visual
test
add
acid
add
ml
n
sulfur
acid
tube
agit
mix
blank
spectrophotomet
substrat
blank
nm
determin
absorb
control
specimen
nm
photometr
method
select
wavelength
nm
spectrophotomet
use
quantum
analyzerabbott
determin
cutoff
valu
calcul
mean
absorb
control
none
individu
control
differ
time
mean
add
obtain
cutoff
valu
gray
zone
defin
time
cutoff
valu
purpos
rabbit
antiserum
rotaviru
incorpor
coat
detector
antibodi
rotavirusneg
rabbit
serum
appli
coat
antibodi
control
elimin
fals
posit
result
pretreat
stool
edta
increas
specif
sensit
assay
bishop
et
al
express
activ
rotaviru
antibodi
human
sera
unit
deriv
standard
curv
method
success
adapt
de
savigni
voller
found
particular
valu
longitudin
epidemiolog
studi
effect
neonat
rotaviru
infect
recent
new
viral
agent
morpholog
indistinguish
rotavirus
antigen
differ
gs
antigen
observ
rodger
et
al
nicola
et
al
medic
import
pararotavirus
yet
clear
assay
yet
devis
solidphas
enzym
immunoassay
techniqu
describ
tabl
follow
sandwich
principl
rubenstein
et
al
market
abbott
laboratori
method
plastic
bead
coat
guinea
pig
antibodi
rotaviru
rotaviru
sampl
suspens
aliquot
patient
fece
ad
bead
immobil
guinea
pig
antibodi
solid
phase
wash
antirotaviru
conjug
peroxidas
ad
antibodi
bound
viru
present
result
enzymat
activ
addit
substrat
yolken
et
al
sheridan
et
al
found
immobil
guinea
pig
antibodi
gave
reliabl
result
direct
adsorpt
rotaviru
antigen
howev
detect
antibodi
rotavirus
adsorpt
antigen
solid
phase
desir
epidemiolog
survey
ghose
et
al
use
antigen
directli
adsorb
solid
phase
inouy
et
al
found
rotaviru
antigen
could
effici
adsorb
solid
phase
pretreat
chaotrop
agent
nascn
guanidinehcl
order
detect
fecal
antibodi
excess
protein
eg
fetal
calf
serum
ad
protect
antigen
proteolyt
activ
fece
recent
investig
beard
et
al
observ
inclus
edta
buffer
dilut
antigen
increas
detectabihti
assay
consider
probabl
due
convers
rotaviru
particl
incomplet
form
thu
expos
rotaviru
group
antigen
cohen
edta
may
thu
effect
reduc
fals
neg
result
sampl
contain
predominantli
complet
particl
beard
bryden
edta
use
high
concentr
sinc
particularli
neonat
sampl
may
high
calcium
ion
level
irradi
plastic
higher
antibodi
bind
capac
plastic
though
pretreat
hr
glutaraldehyd
rais
perform
beard
et
al
brandt
et
al
report
elisa
fals
posit
result
beard
et
al
suggest
fals
posit
result
depend
reagent
use
particular
rheumatoid
factor
plastic
coat
hyperimmun
guinea
pig
rotaviru
serum
dilut
time
carbon
buffer
ph
incub
overnight
hr
plastic
allow
dri
store
use
preliminari
test
optim
temperatur
antigenantibodi
interact
determin
may
vari
wide
eg
antibodi
react
best
room
temperatur
react
wherea
other
commerci
kit
abbott
laboratori
react
best
assay
reagent
brought
room
temperatur
plate
incub
use
wherea
tube
plastic
bead
tube
water
bath
usual
choic
present
antibodi
guinea
pig
coat
plastic
bead
assay
ml
control
dilut
specimen
vv
fecal
extract
pb
clarifi
centrifug
immedi
use
dilut
pb
contain
edta
pipet
appropri
tube
one
coat
bead
dispens
tube
mix
tap
tube
cover
incub
hr
bead
rins
four
time
ml
water
conjug
antirotaviru
antibodi
rabbit
label
peroxidas
ad
mlbead
cover
tube
incub
hr
bead
wash
six
time
ml
water
transfer
tube
assay
tube
ophenylenediamin
ad
mgml
citratephosph
buffer
ph
contain
hydrogen
peroxid
use
substrat
ml
ad
bead
incub
min
room
temperatur
optic
densiti
may
read
color
chart
ml
n
sulfur
acid
ad
nm
detail
procedur
detect
rotaviru
antigen
use
rotazym
kit
abbott
laboratori
describ
tabl
day
rotaviru
antigen
difficult
detect
follow
method
inouy
et
al
use
purifi
inner
capsid
particl
densiti
gcm
mix
equal
volum
nascn
incub
min
room
temperatur
antigen
dilut
carbon
buffer
ph
dispens
well
incub
overnight
wash
three
time
pb
contain
tween
pbst
sampl
fece
dilut
pbst
contain
bsa
fetal
calf
serum
fc
ad
incub
hr
room
temperatur
wash
well
conjug
pbst
bsa
ad
incub
hr
room
temperatur
order
detect
fecal
antibodi
excess
protein
eg
fetal
calf
serum
ad
protect
rotaviru
antigen
proteolyt
activ
fece
enzym
reveal
describ
bsa
much
less
effect
fc
prevent
proteolysi
constitu
fece
though
antibodi
differ
speci
could
use
trap
rotaviru
antigen
solid
phase
crossreact
sampl
antibodi
may
problem
detect
rotavirusspecif
igg
antibodi
indirect
immunoperoxidas
method
enzymelink
immunosorb
assay
also
propos
use
antigen
rotaviru
infect
cell
parallel
rotavirusspecif
igg
antibodi
determin
elisa
zentner
et
al
year
ago
norwalk
viru
visual
immunoelectron
microscopi
stool
specimen
obtain
outbreak
gastroenter
kapikian
et
al
viru
physic
properti
morpholog
parvovirus
howev
observ
greenberg
et
al
viru
contain
one
protein
r
confirm
probabl
member
calicivirus
rna
contain
viru
shed
low
titer
greenberg
et
al
make
difficult
prepar
hyperimmun
anim
serum
reagent
diagnosi
current
ria
test
procedur
use
reli
fecal
serum
sampl
experiment
infect
volunt
new
serotyp
adenovirus
isol
stool
specimen
case
infantil
gastroenter
de
jong
et
al
recogn
rotaviru
common
agent
infantil
gastroenter
brandt
et
al
though
virus
grow
standard
tissu
cultur
grown
graham
cell
takiff
et
al
product
reagent
enzym
immunoassay
possibl
adult
antibodi
caliciviru
sakuma
et
al
detect
virus
reli
electron
microscopi
recent
solidphas
ria
develop
nakata
et
al
enzym
immunoassay
expect
soon
coronaviruslik
particl
also
associ
gastroenter
though
definit
role
assess
sinc
particl
observ
similar
proport
healthi
individu
cukor
blacklow
astrovirus
grown
vitro
make
difficult
prepar
diagnost
reagent
diagnosi
still
reli
primarili
immunoelectron
microscopi
kanno
et
al
sever
virus
etiolog
import
associ
syndrom
though
clinic
symptom
mani
differ
virus
may
induc
infect
howev
prevent
reiter
mani
differ
possibl
virus
caus
syndrom
import
discuss
upper
respiratori
tract
infect
virus
may
lead
common
cold
undifferenti
febril
upper
respiratori
ill
pharyng
pharyngoconjunctiv
fever
lower
respiratori
tract
infect
lead
laryngotracheobronch
bronchiol
infant
children
bronchiti
children
adult
pneumonia
virus
may
involv
list
tabl
though
list
probabl
incomplet
major
upper
respiratori
tract
infect
caus
virus
occur
individu
age
croup
acut
laryngotrach
primarili
associ
parainfluenza
among
lower
respiratori
tract
infect
bacteri
infect
much
import
perhap
onethird
total
particularli
case
pneumonia
viral
pneumonia
occur
primarili
young
old
respiratori
handicap
addit
virus
measl
chickenpox
rubella
start
respiratori
tract
infect
resist
infect
influenza
associ
antibodi
hemagglutinin
neuramidas
virelizor
et
al
antibodi
intern
protein
tradit
hemagglutinin
neuramidas
inhibit
test
rel
insensit
turner
et
al
compar
elisa
hemagglutinin
inhibit
ahi
test
found
increas
geometr
mean
antibodi
titer
elisa
wherea
hai
depend
antigen
use
assay
infect
julkunen
et
al
found
also
efficaci
enzym
immunoassay
detect
diagnost
antibodi
use
influenza
b
virus
higher
compar
complement
fixat
hemagglutin
inhibit
test
presenc
antibodi
test
sera
nasal
wash
murphi
et
al
detect
elisa
primarili
iggisotyp
antibodi
influenza
sera
igaisotyp
antibodi
nasal
wash
antibodi
manifest
hemagglutin
subgroup
specif
therefor
murphi
et
al
devis
sensit
elisa
hemagglutinin
instead
whole
viru
similarli
khan
et
al
develop
elisa
influenza
viru
neuramidasespecif
antibodi
khan
et
al
also
develop
elisa
protein
isol
sdsgel
chromatographi
antibodi
gener
present
patient
sever
ill
hammond
et
al
note
lack
subtyp
specif
elisa
use
endpoint
titer
find
differ
point
mador
et
al
method
may
inadequ
mador
et
al
observ
significantli
greater
antibodi
concentr
influenza
infect
area
doserespons
curv
consid
area
gener
two
respons
curv
endpoint
method
mani
data
process
method
also
reli
assumpt
doserespons
curv
parallel
fact
curv
may
becom
steeper
without
increas
endpoint
addit
influenza
b
influenza
c
recogn
human
pathogen
inform
limit
difficulti
propag
viru
austin
et
al
succeed
adapt
viru
grow
allanto
caviti
embryon
egg
larg
quantiti
reagent
thu
prepar
elisa
design
viru
troisi
monto
test
appear
sensit
remov
potenti
interf
chicken
qgg
albumin
antibodi
heat
treatment
min
serum
case
found
increas
read
viru
seem
ubiquit
appar
infect
occur
frequent
differenti
strain
influenza
virus
requir
use
constitu
protein
instead
whole
viru
alkaissi
mostrato
influenza
virus
adsorb
surfac
polystyren
found
ruptur
adsorpt
process
expos
nucleoprotein
abl
react
antibodi
probabl
specif
enzym
immunoassay
resembl
complement
fixat
test
rather
hemagglutin
test
hammond
et
al
howev
hemagglutinin
neuramidas
prepar
gener
avail
adsorpt
complet
viru
polystyren
inactiv
neuramidas
least
one
strain
alkaissi
mostrato
respiratori
diseas
diagnos
isol
agent
cell
cultur
embryon
egg
detect
antigen
cell
immunofluoresc
immunoperoxidas
speed
diagnosi
sensit
harmon
pawlik
develop
elisa
direct
detect
influenza
antigen
without
prior
cultiv
virusspecif
guinea
pig
immunoglobulin
coat
polystyren
microtit
plate
antigen
captur
specimen
follow
success
incub
virusspecif
rabbit
antiserum
goat
antirabbit
immunoglobulin
antibodi
conjug
peroxidas
detect
limit
standard
test
equal
tcid
unit
inclus
gelatin
last
two
incub
increas
sensit
decreas
background
also
interestingli
increas
read
method
detect
isolationposit
clinic
specimen
harmon
pawlik
obtain
similar
result
detect
respiratori
adenoviru
import
note
patient
clinic
find
influenza
viru
infect
viru
shed
ksiazek
et
al
possibl
increas
sensit
antigen
detect
elisa
significantli
new
techniqu
avail
though
hemagglutin
prepar
gener
avail
rel
simpl
purifi
phelanera
parainfluenza
virus
common
caus
acut
respiratori
ill
infant
children
tradit
laboratori
diagnosi
involv
isol
viru
throat
swab
nasopharyng
secret
cultiv
primari
kidney
cell
cultur
howev
difficulti
transport
storag
parainfluenza
virus
notori
infect
rapidli
lost
identif
viru
produc
cell
achiev
hemadsorpt
guinea
pig
erythrocyt
hemagglutinin
inhibit
method
expens
time
consum
hand
immun
respons
may
also
take
week
wong
et
al
found
immunofluoresc
assay
antigen
nasopharyng
epitheli
cell
reliabl
faster
sarkkinen
et
al
b
compar
immunofluoresc
radioimmunoassay
enzym
immunoassay
detect
parainfluenza
type
found
excel
agreement
note
nasopharyng
wash
contain
littl
antigen
posit
case
radioand
enzym
immunoassay
contrast
aspir
secret
mucou
extractor
nostril
nasopharynx
yield
specimen
gave
sonic
min
sonic
microtip
excel
result
fals
posit
observ
though
author
advis
block
test
low
absorb
valu
ukkonen
et
al
devis
elisa
parainfluenzatyp
antibodi
detect
increas
igm
antibodi
case
increas
antibodi
titer
complement
fixat
method
van
der
logt
et
al
confirm
observ
detect
igm
antibodi
low
proport
infect
recent
julkunen
compar
enzym
immunoassay
complement
fixat
test
parainfluenza
viru
antibodi
studi
perform
patient
respiratori
symptom
eia
found
bring
significantli
diagnost
rise
parainfluenza
viru
type
antibodi
compar
cf
test
enzym
immunoassay
could
diagnost
procedur
choic
parainfluenza
viru
infect
reinfect
frequent
viru
replic
usual
limit
upper
respiratori
tract
consequ
antibodi
respons
often
remain
faint
fact
enzym
immunoassay
viabl
viru
requir
great
advantag
parainfluenza
virus
sinc
inactiv
rapidli
stress
parkinson
et
al
could
detect
parainfluenza
antigen
cultur
residu
infecti
viru
could
longer
recov
sensit
indirect
enzym
immunoassay
equal
hemagglutinin
unit
parainfluenza
viru
type
wherea
type
sensit
enzym
immunoassay
equal
hemagglutinin
unit
rsv
infect
primarili
young
diagnos
laboratori
rapid
inocul
cell
cultur
possibl
laboratori
near
hospit
disadvantag
confirm
take
day
enzym
immunoassay
therefor
prime
candid
diagnost
purpos
wide
appli
chao
et
al
sarkkinena
hornsletha
hornsletha
mclntosh
meurman
et
al
b
mclntosh
et
al
observ
specimen
transport
great
problem
enzym
immunoassay
sinc
specimen
left
day
room
temperatur
equal
reactiv
chao
et
al
hornsleth
et
al
meurman
et
al
compar
immunoassay
antigen
viru
isol
procedur
cell
cultur
show
clinic
sensit
assay
hornsleth
et
al
observ
howev
enzym
immunoassay
sensit
children
month
age
observ
confirm
meurman
etal
serolog
examin
enzym
immunoassay
devalu
clinic
symptom
suggest
rsvinduc
diseas
sinc
fals
neg
occur
frequent
meurman
et
al
igg
level
rel
high
signific
increas
period
test
enzym
immunoassay
clearli
superior
complement
fixat
hornsleth
et
al
young
patient
matern
antibodi
may
interfer
igm
antibodi
indic
acut
infect
mani
virus
often
absent
rsv
infect
though
abil
produc
igm
antibodi
seem
increas
age
welliv
et
al
meurman
et
al
iga
antibodi
frequent
absent
presenc
singl
test
indic
recent
infect
sinc
antibodi
may
persist
prolong
period
welliv
et
al
kraaijeveld
et
al
describ
elisa
detect
antibodi
human
coronaviru
macnaughton
et
al
develop
assay
detect
coronaviru
antigen
nose
swab
throat
swab
nasopharyng
aspir
children
natur
acquir
respiratori
infect
sampl
least
particlesml
detect
twice
mani
posit
obtain
noseswab
specimen
throat
swab
nasopharyng
aspir
schmidt
kenni
shown
human
coronavirus
contain
three
differ
antigen
schmidt
develop
elisa
investig
natur
polypeptid
crossreact
found
antigen
coronavirus
preval
human
antibodi
found
direct
virion
peplom
measl
start
respiratori
viral
infect
long
recogn
one
major
diseas
childhood
marusyk
tyrrel
often
involv
central
nervou
system
norrbi
complic
especi
malnourish
child
includ
pneumonia
otiti
media
diarrhea
enceph
subacut
scleros
panenceph
sspe
enzym
immunoassay
test
enzygnost
develop
hoechst
institut
base
detect
specif
igm
antibodi
measl
infect
igm
antibodi
appear
within
first
day
onset
rash
persist
day
prolong
igm
antibodi
respons
also
observ
minor
patient
sspe
postmeasl
enceph
prolong
igg
antibodi
respons
may
occur
sspe
afflict
patient
alway
show
time
higher
level
specif
igg
convalesc
acut
measl
infect
hoechst
enzygnost
test
antibodi
viral
antigen
igm
igg
present
serum
sampl
incub
respect
antigen
fix
well
micropl
antibodi
specif
viru
antigen
bound
solidphas
antigen
incub
hr
consequ
antihuman
igg
rabbit
chain
specif
antihuman
igm
rabbit
chain
specif
conjug
alkalin
phosphatas
incub
previous
form
solidphas
antigenantibodi
complex
antihuman
igg
conjug
antihuman
igm
conjug
bound
antigenantibodi
complex
form
sandwich
addit
chromogen
substrat
pnitrophenyl
phosphat
dissolv
substrat
buffer
solut
result
yellowishgreen
color
specif
antibodi
present
patient
sampl
enzymat
reaction
stop
addit
ml
n
naoh
per
well
photometr
evalu
result
obtain
includ
read
plate
calcul
print
result
automat
perform
behr
elisaprocessor
common
caus
prenat
infect
man
cytomegaloand
rubella
virus
contamin
rate
cytomegaloviru
rang
adult
popul
develop
countri
develop
countri
low
socioeconom
group
krech
jung
like
herp
virus
cytomegaloviru
persist
latent
wide
varieti
often
subclin
symptom
make
diagnosi
difficult
main
effect
intrauterin
infect
hepatosplenomegali
diseas
central
nervou
system
rubella
usual
benign
problem
infect
may
aris
first
trimest
pregnanc
women
childbear
age
antibodi
protect
igm
antibodi
cmv
excel
marker
congenit
recent
acquir
cmv
infect
immunoperoxidas
procedur
gerna
chamber
b
enzym
immunoassay
schmitz
et
al
particularli
classcaptur
assay
schmitz
et
al
van
loon
et
al
use
explain
eia
phenomenon
howev
igm
antibodi
product
highli
variabl
follow
secondari
infect
sutherland
brigg
remov
rheumatoid
factor
essenti
prevent
fals
posit
kangro
et
al
booth
et
al
booth
et
al
develop
cmv
iggantibodi
test
compar
serolog
method
poor
correl
found
ria
eia
titer
seem
differ
antibodi
label
two
test
anticompl
immunoperoxidas
method
offer
sensit
method
specif
detect
intranuclear
inclus
bodi
infect
cell
fig
intranuclear
inclus
bodi
specif
stain
wherea
intracytoplasm
inclus
bodi
observ
insignific
background
stain
posit
cmv
serum
dilut
fresh
cmvneg
serum
ad
complement
conjug
dilut
courtesi
dr
yoichi
minamishima
dr
seigo
yamamoto
permiss
reproduc
kurstak
et
al
use
light
electron
microscop
immunoperoxidas
stain
detect
cytomegaloviru
antigen
infect
human
fibroblast
possibl
shorten
substanti
time
necessari
diagnos
infect
comparison
cpe
method
recent
sarov
haikin
propos
potenti
applic
indirect
immunoperoxidas
iga
assay
serodiagnosi
cmv
infect
use
sequenti
serum
sampl
patient
sinc
persist
iga
antibodi
depend
viru
involv
individu
variat
among
patient
importantli
sensit
method
use
detect
specif
iga
immunoperoxidas
iga
assay
suggest
anoth
work
singer
et
al
adopt
immunoperoxidas
method
detect
serum
igm
antibodi
cmv
antigen
consist
cmv
infect
human
embryon
fibroblast
isol
nuclei
rabbit
antihuman
igm
peroxidas
conjug
use
detect
igm
bound
viral
antigen
indirect
immunoperoxidas
also
recommend
advantag
method
diagnos
evalu
cmv
mononucleosi
abramowitz
et
al
classcaptur
assay
rubellaspecif
igm
antibodi
prove
simpl
sensit
specif
altern
igm
antirubella
test
compar
favor
approach
isaac
payn
method
develop
duermey
van
der
veen
avoid
time
consum
expens
physic
separ
igg
igm
sucros
densiti
gradient
centrifug
exclus
chromatographi
vesikari
vaheri
gupta
et
al
classcaptur
assay
use
f
ab
conjug
prove
reliabl
sensit
isaac
payn
remov
nonspecif
inhibitor
necessari
volum
sampl
requir
clinic
valid
antibodycaptur
antirubella
igmimmunoassay
perform
wielaard
et
al
studi
use
monoclon
antibodi
igm
found
eia
sera
total
sera
known
contain
antirubella
igm
sucros
densiti
gradient
method
second
studi
acut
rubella
infect
detect
igmeia
specif
antibodycaptur
eia
high
interfer
seen
rheumatoidfactor
posit
sera
highli
posit
igg
sera
recent
bonfanti
et
al
develop
new
solid
phase
enzym
immunoassay
detect
rubellaspecif
igg
procedur
use
polystyren
microtit
strip
coat
rabbit
antihuman
igg
immunoglobulin
solid
phase
enzymelabel
semipurifi
rubella
antigen
indic
advantag
direct
enzym
immunoassay
method
label
antigen
use
test
differ
class
immunoglobulin
use
simpli
solid
phase
coat
captur
antibodi
differ
chain
specif
best
et
al
demonstr
problem
may
occur
detect
rubellaspecif
igm
rubazymem
abbott
diagnost
mantibodi
captur
radioimmunoassay
macria
recommend
result
rubellaspecif
igm
interpret
caution
rubazymem
current
recommend
manufactur
diagnosi
congenit
rubella
examin
cord
blood
support
best
et
al
found
fals
neg
neonat
evid
intrauterin
infect
contrast
fals
posit
result
due
rheumatoid
factor
antinuclear
antibodi
obtain
rubellaspecif
igm
detect
sera
patient
infecti
mononucleosi
may
due
ebv
stimul
b
lymphocyt
specif
rubella
result
incorpor
cellular
antigen
lipoprotein
envelop
rubella
viru
use
antigen
morgancapn
etal
kurtz
malic
show
disadvantag
elisa
system
presenc
rheumatoid
factor
may
caus
fals
posit
result
rf
attach
patient
igg
rubella
antibodi
solid
phase
react
alter
igg
conjug
overcom
latter
problem
remov
alter
igg
conjug
conjug
fab
portion
anoth
possibl
assur
specif
perform
duplic
test
serum
omit
addit
antigen
diagnosi
rubella
viru
clinic
materi
use
immunoperoxidas
method
also
satisfactori
patient
specimen
inocul
hamster
kidley
cell
schmidt
et
al
numer
techniqu
develop
identif
type
herp
simplex
viru
serolog
techniqu
includ
immunofluoresc
nahmia
et
al
immunoperoxidas
fig
benjamin
kurstak
kurstak
morisset
et
al
gerna
chamber
hemagglutin
bernstein
stewart
mix
agglutin
ito
bairon
microneutr
counterimmunoelectrophoresi
jeansson
radioimmunoassay
forghani
al
enzym
immunoassay
vestergaard
jensen
frame
et
al
contrari
initi
belief
hsv
type
frequent
caus
genit
lesion
isol
balachandran
etal
import
sinc
hsv
type
infect
differ
hsv
type
infect
respect
recurr
respons
chemotherapi
associ
cervic
carcinoma
de
clercq
et
al
rawl
et
al
reev
et
al
frame
et
al
develop
doubleantibodi
enzym
immunoassay
hsv
type
employ
polyclon
rabbit
captur
antiserum
typecommon
type
monoclon
antibodi
killington
et
al
detector
assay
sensit
specif
compar
cell
cultur
restrict
endonucleas
analysi
type
index
ratio
optic
densiti
hsvtype
common
antibodi
optic
densiti
type
antibodi
select
distinguish
type
isol
type
antigen
also
detect
direct
immunoperoxidas
method
cytosmear
cervic
scrape
fig
well
antigen
bulla
typic
erythema
multiform
lesion
mild
recurr
local
skin
infect
major
et
al
import
test
varicellazost
viru
fatal
immunocompromis
patient
cytotox
therapi
whreghitt
et
al
forghani
et
al
develop
indirect
varicellazost
viru
en
zyme
immunoassay
wherea
whreghitt
et
al
devis
competit
varicellazost
viru
enzym
immunoassay
though
complement
fixat
test
usual
satisfactori
surprisingli
inadequ
detect
antivaricellazost
viru
antibodi
sera
hemodialysi
patient
competit
enzym
immunoassay
specif
indirect
assay
though
potenti
sensit
lower
kurstak
howev
time
sensit
complement
fixat
whreghitt
et
al
cox
et
al
develop
situ
enzym
immunoassay
viral
membran
antigen
enabl
specif
estim
antibodi
varicellazost
viru
rapid
screen
test
antibodi
possibl
inclus
zoster
immun
globulin
pool
use
allevi
sever
clinic
effect
infect
particularli
due
shortag
immun
globulin
essenti
purpos
cell
fix
glutaraldehyd
situ
enzym
immunoassay
expect
specif
membran
varicellazost
viru
antigen
wherea
crossreact
intern
antigen
express
host
membran
interfer
also
diagnost
purpos
immunoperoxidas
method
appli
success
detect
antigen
materi
herp
zoster
viru
cutan
lesion
patient
dendrit
kerat
laflamm
et
al
immunoperoxidas
method
sensit
specif
method
detect
antigen
relat
ebv
kurstak
et
al
van
der
hurk
kurstak
anticompl
immunoperoxidas
method
capabl
detect
ebv
nuclear
antigen
ebna
high
serum
dilut
fig
similar
stain
pattern
obtain
anticompl
immunofluoresc
techniqu
reedman
klein
howev
unlik
immunofluoresc
techniqu
immunoperoxidas
techniqu
allow
detect
ebna
indirect
method
viral
capsid
antigen
vca
earli
antigen
ea
also
detect
sensit
method
recent
enzymelink
immunosorb
assay
develop
detect
antibodi
eb
viru
membran
antigen
glycoprotein
tamarin
epstein
method
found
thousandfold
sensit
convent
indirect
immunofluoresc
test
human
serum
type
seroneg
immunofluoresc
techniqu
gave
titer
elisa
develop
measur
specif
antibodi
glycoprotein
subunit
epsteinbarr
viru
membran
antigen
assay
suitabl
monitor
high
sensit
sequenti
product
specif
antibodi
tamarin
assess
vaccin
procedur
vivo
papillomavirus
etiolog
agent
wart
propag
vitro
distinct
viru
type
character
gissmann
zur
hausen
gissmann
et
al
recent
renew
interest
group
virus
previous
consid
benign
suspicion
grown
papillomavirus
associ
human
cancer
zur
hausen
meisel
morin
braun
et
al
compar
histolog
diagnos
wart
cutan
broadli
crossreact
antiserum
dysplasia
mean
immunoperoxidas
techniqu
frequenc
occurr
pattern
distribut
papillomaviru
capsid
antigen
viral
hepat
caus
differ
virus
hepat
hepat
b
hepat
nona
nonb
sometim
entero
virus
herp
virus
cytomegalovirus
yellow
fever
viru
rubella
epsteinbarr
virus
system
diseas
primarili
involv
liver
infecti
hepat
shortincub
hepat
epidem
jaundic
gener
caus
type
viru
hepat
viru
wherea
serum
hepat
longincub
hepat
caus
type
b
viru
hepat
b
viru
major
form
posttransfus
hepat
mani
develop
countri
nona
nonb
hepat
sinc
frequenc
hepat
b
infect
reduc
due
care
screen
donor
blood
dienstag
et
al
still
wide
use
method
detect
hepat
particl
immunoelectron
microscopi
feinston
et
al
allow
detect
viru
solut
contain
particlesml
direct
detect
antigen
valu
research
laboratori
clinic
diagnosi
sinc
maximum
shed
viru
occur
develop
liver
abnorm
rakela
mosley
titer
antihepat
virusposit
antisera
gener
high
skinhoj
et
al
reliabl
method
would
detect
igm
antibodi
hav
howev
could
use
week
postinfect
sinc
detect
usual
occur
week
depend
detect
assay
classcaptur
assay
duermey
van
der
veen
duermey
et
al
avail
abbott
laboratori
gener
employ
antiigm
antibodi
chain
coat
plastic
sensit
solid
phase
retriev
igm
serum
among
igm
antibodi
present
bind
subsequ
ad
hav
antigen
antigen
detect
human
antihav
antibodi
label
peroxidas
stool
sampl
prepar
holling
dienstag
dilut
g
sampl
five
time
mm
trishcl
buffer
ph
homogen
shake
vigor
glass
bead
sampl
clear
centrifug
min
g
subsequ
extract
chloroform
subject
differenti
centrifug
hr
rpm
hr
rpm
beckman
type
rotor
pellet
obtain
resuspend
trishcl
buffer
ml
layer
cushion
ml
cscl
gml
centrifug
rifi
hbsag
serum
test
brought
contact
immobil
antigen
extract
antibodi
unbound
materi
wash
biotinyl
hbsag
ad
bind
turn
antibodi
avidinperoxidas
complex
ad
immobil
biotin
presenc
antibodi
test
serum
result
yellow
color
substrat
ad
ionescumatia
et
al
develop
two
micro
solidphas
enzym
immunoassay
detect
antihb
antibodi
improv
detect
reduc
high
cost
commerci
kit
larg
volum
materi
requir
latter
test
hbsag
adw
dilut
carbon
buffer
ph
protein
concentr
solut
brought
well
rigid
polystyren
plate
left
hr
well
postcoat
gelatin
ph
ph
conjug
prepar
spdp
found
question
stabil
nevertheless
abl
detect
antihb
antibodi
titer
time
higher
geometr
mean
commerci
kit
modifi
design
caution
warrant
sinc
variou
compon
normal
human
serum
may
associ
hbsag
particl
schuur
wolter
mani
experiment
antihb
antisera
may
thu
crossreact
normal
human
serum
compon
could
lead
nonspecif
rise
titer
nonspecif
test
reduc
inclus
normal
human
serum
antiserum
normal
compon
would
neutral
nonspecif
antibodi
hbsag
detect
method
describ
wei
et
al
wolter
et
al
antihb
antibodi
guinea
pig
immobil
solid
phase
hbsag
present
serum
bound
antibodi
peroxidaselabel
antihbsag
antibodi
may
detect
immobil
antigen
improv
sandwich
enzymelink
immunosorb
assay
elisa
hepat
b
viru
surfac
antigen
develop
recent
use
monoclon
antihb
solid
phase
horseradish
peroxidaselabel
sheep
antihb
wolter
et
al
sensit
method
uml
hbsag
standard
test
procedur
two
incub
step
min
slightli
reduc
sensit
uml
note
two
incub
combin
onestep
incub
min
test
hbe
essenti
antibodyantigenantibodi
sandwich
core
antigen
hbcag
appear
serum
somewhat
later
hbsag
persist
latter
disappear
therefor
marker
hbv
infect
subsequ
appear
antihb
antibodi
elisa
procedur
hbv
antibodi
licens
north
america
cordia
h
cordi
corp
auszym
abbott
laboratori
wherea
europ
hepanostika
organon
oss
enzygnost
antihb
eia
hoechstbehr
frequent
use
cordi
use
disk
wherea
abbott
use
bead
solid
phase
organon
hoechstbehr
use
microtit
plate
cordi
behr
use
alkalin
phosphatas
label
wherea
organon
abbott
use
peroxidas
alkalin
phosphatas
superior
stabil
less
sensit
water
contamin
less
sensit
peroxidas
abbott
laboratori
enzym
immunoassay
test
auszym
ii
detect
hepat
b
surfac
antigen
describ
tabl
delta
antigen
rizzetto
et
al
rizzetto
seem
higher
incid
patient
fulmin
hepat
raimondo
et
al
although
acut
simultan
deltahepat
infect
seem
increas
sever
shattock
field
delta
antigen
hepat
viru
appear
larg
hbsag
particl
nm
hbsag
coat
surround
intern
compon
consist
small
rna
molecul
kda
delta
antigen
detect
nucleu
hepatocyt
patient
late
incub
period
begin
acut
phase
mushahwar
et
al
shattock
morgan
develop
enzym
immunoassay
detect
delta
antigen
antidelta
antibodi
design
method
superior
sensit
instead
usual
antigen
prepar
sonic
liver
nuclei
prepar
deriv
antigen
detergenttr
serum
delta
antigen
usual
transient
serum
smedil
et
al
delta
antigenemia
may
frequent
previous
suspect
drug
abus
hnanb
review
extens
gereti
seem
consist
two
distinct
agent
though
nona
nonb
hepat
gener
rather
mild
high
rate
patient
develop
chronic
liver
damag
berman
et
al
case
fulmin
cours
lead
death
hepat
coma
shortli
onset
diseas
duermey
et
al
develop
elisa
detect
antigen
three
neg
two
posit
control
must
test
run
unknown
reaction
tray
contain
control
andor
unknown
subject
process
incub
time
avoid
crosscontamin
separ
dispos
tip
use
transfer
bring
reagent
begin
assay
procedur
swirl
gentli
use
identifi
reaction
tray
well
specimen
control
date
sheet
dispens
neg
control
posit
control
specimen
assign
well
dispens
one
coat
bead
well
appli
cover
sealer
tray
gentli
tap
tray
ensur
bead
cover
sampl
air
bubbl
releas
procedur
incub
tray
water
bath
min
b
incub
tray
hr
level
surfac
c
incub
tray
water
bath
min
continu
end
incub
period
remov
discard
cover
sealer
aspir
content
well
wash
bead
pipet
antibodi
hepat
b
surfac
antigen
goat
peroxidas
conjug
well
appli
cover
sealer
tray
gentli
tap
tray
ensur
bead
cover
conjug
air
bubbl
releas
procedur
b
incub
tray
water
bath
min
procedur
c
incub
tray
water
bath
min
last
min
incub
final
wash
step
prepar
opd
substrat
solut
end
incub
period
remov
tray
water
bath
remov
discard
cover
sealer
aspir
content
well
wash
bead
remov
excess
water
top
tray
aspir
blot
immedi
transfer
bead
well
properli
identifi
assay
tube
align
invert
rack
orient
tube
reaction
tray
press
tube
tightli
well
invert
tray
tube
togeth
bead
fall
correspond
tube
blot
excess
water
top
tube
rack
pipet
freshli
prepar
opd
substrat
solut
tube
contain
bead
two
empti
tube
substrat
blank
incub
tube
min
prevent
accident
liquid
spill
tube
cover
box
incub
complet
incub
stop
enzym
reaction
ad
ml
acid
tube
contain
bead
substrat
blank
allow
acid
solut
come
contact
metal
air
bubbl
remov
prior
read
absorb
select
wavelength
nm
spectrophotomet
use
quantum
analyz
blank
instrument
use
one
two
substrat
blank
tube
read
neg
posit
control
process
unknown
visual
inspect
blank
discard
contamin
indic
yelloworang
color
blank
contamin
entir
run
must
repeat
note
follow
read
specimen
absorb
greater
cuvett
thoroughli
rins
distil
deioniz
water
prior
read
next
tube
absorb
valu
determin
within
hr
addit
acid
n
h
result
cutoff
valu
determin
presenc
absenc
hbsag
determin
relat
absorb
unknown
sampl
cutoff
valu
cutoff
valu
absorb
neg
control
mean
plu
factor
procedur
b
factor
procedur
c
respect
unknown
sampl
whose
absorb
greater
equal
cutoff
valu
establish
neg
control
consid
reactiv
hbsag
caution
splash
specimen
reagent
outsid
well
high
well
rim
remov
subsequ
wash
may
transfer
tube
caus
test
interfer
abbott
laboratori
antibodi
agent
found
low
frequenc
lowrisk
group
normal
blood
donor
higher
among
eg
patient
hemophilia
prostitut
drug
addict
latter
find
may
confirm
find
szumess
et
al
nona
nonb
hepat
viru
transmit
sexual
litton
bionet
laboratori
develop
elisa
test
base
magnet
bead
intend
detect
antihtlv
antibodi
principl
test
specif
antigen
htlv
ie
bound
polycarbon
surfac
bead
ferrou
metal
suppli
litton
bionet
laboratori
bead
transfer
magnet
devic
solut
contain
serum
antiiggenzym
conjug
substrat
antibodi
present
sampl
bound
antigen
bead
turn
adsorb
conjug
solut
appear
color
bead
place
substrat
solut
indic
presenc
antibodi
materi
requir
test
avail
litton
bionet
kitform
materi
suppli
kit
magnet
transfer
devic
bead
dispens
also
avail
litton
bionet
sera
test
control
sera
neg
posit
dilut
time
dispens
ml
design
well
roundbottom
plate
anoth
plate
antigen
bead
place
use
bead
dispens
bead
transfer
simultan
magnet
transfer
devic
well
sera
plate
contain
sera
bead
incub
min
gentl
rock
transfer
bead
wash
solut
rais
lower
magnet
time
effici
releas
nonspecif
adsorb
materi
transfer
bead
conjugatecontain
ml
well
incub
min
procedur
htlv
bioenzabead
test
kit
provid
litton
bionet
laboratori
product
divis
transfer
bead
sequenti
two
plate
contain
wash
solut
move
bead
respect
two
four
time
wash
solut
transfer
bead
clean
plate
contain
substrat
bionet
htlv
bioenzabead
test
kit
abt
sinc
peroxidas
use
arrest
reaction
min
remov
bead
read
result
white
background
test
read
mirror
white
paper
top
plate
neg
control
sera
neglig
color
usual
incub
period
min
posit
control
serum
yield
definit
light
green
color
color
well
test
sera
essenti
equal
darker
posit
control
sera
consid
posit
acquir
immun
defici
syndrom
aid
may
spread
perinat
parent
sexual
aid
transmit
frequent
blood
transfus
blood
product
donor
infect
lymphotrop
retroviru
type
iii
htlviii
design
also
lymphadenopathyassoci
viru
lav
recent
neurath
et
al
describ
enzymelink
immunoassay
elisa
inhibit
test
detect
antibodi
direct
lav
antigen
pl
protein
applic
test
show
among
individu
belong
group
high
risk
develop
aid
posit
antipl
respect
author
suggest
develop
test
measur
antibodi
viral
antigen
suitabl
solut
lavhtlviii
diagnosi
applic
elisa
immunoperoxidas
techniqu
studi
arbovirus
demonstr
laboratori
kurstak
et
al
charpenti
et
al
mclean
colleagu
could
demonstr
intracytoplasm
replic
california
enceph
ce
viru
domest
wild
mosquito
arctic
region
immunoperoxidas
techniqu
enzym
immunoassay
appli
flavivirus
catanzaro
et
al
bunyavirus
mclean
et
al
alphavirus
stollar
et
al
immunoperoxidas
procedur
also
offer
possibl
compar
light
electron
microscop
level
process
local
viral
antigen
follow
infect
sequenc
differ
alphavirus
sindbi
chikungunya
immunoperoxidas
exampl
cell
infect
chikungunya
viru
contain
reveal
immunoperoxidas
techniqu
antigen
viral
envelop
cytoplasm
membran
fig
intracytoplasm
vacuol
kurstak
et
al
charpenti
et
al
postul
therefor
process
revers
pinocytosi
exocytosi
sinc
specif
stain
vacuolar
membran
incorpor
cytoplasm
membran
envelop
antigen
incorpor
bud
area
cytoplasm
membran
posit
stain
use
immunoperoxidas
techniqu
also
shown
studi
synthesi
antigen
sindbi
virus
method
possibl
demonstr
viru
antigen
insert
plasma
membran
catanzaro
et
al
sindbi
viru
core
antigen
easili
detect
cytoplasm
cer
cell
kurstak
et
al
studi
peroxidaseconjug
staphylococcu
aureu
protein
use
indirect
stain
arboviru
antigen
mosquito
cell
line
zhang
yongh
et
al
demonstr
method
detect
infect
day
appear
cytopath
effect
konishi
yamaoka
propos
rapid
enzymelink
immunosorb
assay
whole
blood
detect
antibodi
japanes
enceph
viru
magnet
process
elisa
system
largescal
epidemiolog
studi
permit
save
total
hr
comparison
ordinari
elisa
procedur
method
seem
use
epidemiolog
studi
arboviru
infect
field
detect
japanes
enceph
viru
antibodi
human
varieti
anim
sera
use
biotinlabel
sandwich
elisa
propos
